AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
218.68
+3.28 (1.52%)
Jun 3, 2026, 2:04 PM EDT - Market open
AbbVie Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,391 | 5,229 | 5,524 | 12,814 | 9,201 | 9,746 |
Short-Term Investments | - | 28 | 31 | 2 | 28 | 84 |
Cash & Short-Term Investments | 9,391 | 5,257 | 5,555 | 12,816 | 9,229 | 9,830 |
Cash Growth | 81.43% | -5.37% | -56.66% | 38.87% | -6.11% | 15.93% |
Accounts Receivable | 12,479 | 12,589 | 10,919 | 11,155 | 11,254 | 9,977 |
Inventory | 5,049 | 4,951 | 4,181 | 4,099 | 3,579 | 3,128 |
Other Current Assets | 6,610 | 6,265 | 4,927 | 4,932 | 4,401 | 4,993 |
Total Current Assets | 33,529 | 29,062 | 25,582 | 33,002 | 28,463 | 27,928 |
Net Property, Plant & Equipment | 5,687 | 5,628 | 5,134 | 4,989 | 4,935 | 5,110 |
Other Intangible Assets | 50,873 | 52,641 | 60,068 | 55,610 | 67,439 | 75,951 |
Goodwill | 35,570 | 35,640 | 34,956 | 32,293 | 32,156 | 32,379 |
Long-Term Investments | 268 | 268 | 279 | 304 | 241 | 277 |
Other Long-Term Assets | 10,536 | 10,721 | 9,142 | 8,513 | 5,571 | 4,884 |
Total Assets | 136,463 | 133,960 | 135,161 | 134,711 | 138,805 | 146,529 |
Accounts Payable | 33,774 | 34,734 | 31,945 | 30,650 | 25,402 | 22,699 |
Short-Term Debt | - | 2,499 | - | - | 1 | 14 |
Current Portion of Long-Term Debt | 8,326 | 6,056 | 6,804 | 7,191 | 4,135 | 12,481 |
Total Current Liabilities | 42,100 | 43,289 | 38,749 | 37,841 | 29,538 | 35,194 |
Long-Term Debt | 64,532 | 58,941 | 60,340 | 52,194 | 59,135 | 64,189 |
Other Long-Term Liabilities | 36,443 | 34,958 | 32,708 | 34,279 | 32,845 | 31,710 |
Total Long-Term Liabilities | 100,975 | 93,899 | 93,048 | 86,473 | 91,980 | 95,899 |
Total Liabilities | 143,075 | 137,188 | 131,797 | 124,314 | 121,518 | 131,093 |
Common Stock | 18 | 18 | 18 | 18 | 18 | 18 |
Treasury Stock | -10,611 | -9,146 | -8,201 | -6,533 | -4,594 | -3,143 |
Additional Paid-in Capital | 22,962 | 22,495 | 21,333 | 20,180 | 19,245 | 18,305 |
Accumulated Other Comprehensive Income | -1,153 | -1,144 | -1,925 | -2,305 | -2,199 | -2,899 |
Retained Earnings | -17,872 | -15,493 | -7,900 | -1,000 | 4,784 | 3,127 |
Total Common Shareholders' Equity | -6,656 | -3,270 | 3,325 | 10,360 | 17,254 | 15,408 |
Minority Interest | 44 | 42 | 39 | 37 | 33 | 28 |
Shareholders' Equity | -6,612 | -3,228 | 3,364 | 10,397 | 17,287 | 15,436 |
Total Liabilities & Equity | 136,463 | 133,960 | 135,161 | 134,711 | 138,805 | 146,529 |
Total Debt | 72,858 | 67,496 | 67,144 | 59,385 | 63,271 | 76,684 |
Net Cash (Debt) | -63,467 | -62,239 | -61,589 | -46,569 | -54,042 | -66,854 |
Net Cash Per Share | -35.80 | -35.10 | -34.74 | -26.27 | -30.39 | -37.62 |
Book Value | -6,656 | -3,270 | 3,325 | 10,360 | 17,254 | 15,408 |
Book Value Per Share | -3.75 | -1.84 | 1.88 | 5.84 | 9.70 | 8.67 |
Tangible Book Value | -93,099 | -91,551 | -91,699 | -77,543 | -82,341 | -92,922 |
Tangible Book Value Per Share | -52.52 | -51.64 | -51.72 | -43.74 | -46.31 | -52.29 |